Subscribe to RSS
DOI: 10.1055/s-0029-1219385
Direct Synthesis of N-Aryl Derivatives of Quinazolin-4(3H)-ones Employing Arylboronic Acids in the Presence of Cu(OAc)2
Publication History
Publication Date:
10 February 2010 (online)
Abstract
Copper-promoted N-arylation of quinazolin-4(3H)-ones with boronic acid at room temperature in the presence of air has been investigated. This method is general and can be applied to synthesizing derivatives of quinazolin-4(3H)-one with medicinal values.
Key words
Cu(OAc)2 - boronic acid - quinazolin-4(3H)-one
-
1a
Armarego WLF. QuinazolinesBrown DJ. John Wiley and Sons; London: 1967. -
1b
Ellis GP. Synthesis of Fused Heterocycles Vol. 47: John Wiley and Sons; Chichester: 1987. -
1c
Hermecz I.Kokosi J.Podanyi B.Szasz G. Heterocycles 1994, 37903 -
1d For review on quinazolinone,
see:
Mhaske SB.Argade NP. Tetrahedron 2006, 62: 9787 - 2
Fowler KW,Huang D,Kesicki EA,Ooi HC,Oliver AR,Ruan F, andTreiberg J. inventors; WO 2005113556, 2005-6, US 16778. ; Chem. Abstr. 2006, 144, 22759 - 3
Jiang JB.Hesson DP.Dusak BA.Dexter DL.Kang GJ.Hamel E. J. Med. Chem. 1990, 33: 1721 - 4
Lowe JA.Archer RL.Chapin DS.Cheng JB.Helweg D.Johnson JL.Koe BK.Lebel LA.Moore PF.Nielsen JA.Russo LL.Shirley JT. J. Med. Chem. 1991, 34: 624 - 5
Rudolph J.Esler WP.O’Connor S.Coish PDG.Wickens PL.Brands M.Bierer DE.Bloomquist BT.Bondar G.Chen L.Chuang C.-Y.Claus TH.Fathi Z.Fu W.Khire UR.Kristie JA.Liu X.-G.Lowe DB.McClure AC.Michels M.Ortiz AA.Ramsden PD.Schoenleber RW.Shelekhin TE.Vakalopoulos A.Tang W.Wang L.Yi L.Gardell SJ.Livingston JN.Sweet LJ.Bullock WH. J. Med. Chem. 2007, 50: 5202 -
6a
Katritzky AR.Rees CW. The Structure, Reaction, Synthesis and Uses of Heterocyclic Compounds, In Comprehensive Heterocyclic Chemistry Part 2B, Vol. 3: Pergamon Press; New York: 1984. -
6b
Pelletier SW. Alkaloids: Chemical and Biological Prospective Vol. 1: John Wiley and Sons; New York: 1983. - 7
Takeuchi Y.Koike M.Azuma K.Nishioka H.Abe H.Kim H.-S.Wataya Y.Harayama T. Chem. Pharm. 2001, 49: 721 -
8a
Tsantrizos YS.Xu X.-J. Can. J. Chem. 1993, 71: 1362 -
8b
Wang H.Genesan A. J. Org. Chem. 1998, 63: 2432 -
8c
He F.Snider BB. J. Org. Chem. 1999, 64: 1397 -
8d
Sugimori T.Okawa T.Egushi S.Kakehi A.Yashima E.Okamoto Y. Tetrahedron 1998, 54: 7997 -
9a
Kotsuki H.Sakai H.Morimoto H.Suenaga H. Synlett 1999, 1993 -
9b
Khosropour AR.Mohammafpoor-Baltork I.Ghorbankhani H. Tetrahedron Lett. 2006, 47: 3561 -
9c
Narasimhulu M.Mahesh KC.Reddy TS.Rajesh K.Venkateswarlu Y. Tetrahedron Lett. 2006, 47: 4381 -
10a
Kametani T.Loc CV.Higa T.Koizumi M.Ihara M.Fukumoto K. J. Am. Chem. Soc. 1997, 99: 2306, -
10b
Connolly DJ.Guiry PJ. Synlett 2001, 1707 -
10c
Wang L.Xia J.Qin F.Qin C.Sun J. Synthesis 2003, 1241 - 11
Salehi P.Dabiri M.Zolfigol MA.Bahgbanzadeh M. Tetrahedron Lett. 2004, 46: 7151 - 12
Xue S.McKenna J.Shieh WC.Repi O. J. Org. Chem. 2004, 69: 6474 - 13
Shi D.Rong L.Wang J.Zhuang Q.Wang X.Hu H. Tetrahedron Lett. 2003, 44: 3199 -
14a
Kamal A.Reddy KS.Prasad BR.Babu AH.Ramana AV. Tetrahedron Lett. 2004, 45: 6-517 -
14b
Kalusa A.Chessum N.Jones K. Tetrahedron Lett. 2008, 49: 5840 -
15a
Chan DMT.Monaco KL.Wang R.-P.Winters MP. Tetrahedron Lett. 1998, 39: 2933 -
15b
Lam PYS.Clark CG.Saubern S.Adams J.Winters MP.Chan DMT.Combs A. Tetrahedron Lett. 1998, 39: 2941 -
15c
Chan DMT.Lam PYS. Recent Advances in Copper-Promoted C-Heteroatom Bond Cross-Coupling Reaction with Boronic Acids and Derivatives, In Boronic Acids: Preparation and Application in Organic Synthesis and MedicineHall DG. Wiley-VCH; Weinheim: 2005. p.205 -
16a
Lam PYS.Deudon S.Averil KM.Li R.He M.DeShong P.Clark CG. J. Am. Chem. Soc. 2000, 122: 7600 -
16b
Lam PYS.Vincent G.Bonne D.Clark CG. Tetrahedron Lett. 2002, 43: 3091 -
16c
Chan DMT.Monaco KL.Li R.Bonne D.Clark CG.Lam PYS. Tetrahedron Lett. 2003, 44: 3863 -
17a
Evans DA.Katz JL.Peterson GS.Hinterman T. J. Am. Chem. Soc. 2001, 123: 12411 -
17b
Collman JP.Zhong M.Zhang C.Costanzo S. Org. Lett. 2001, 66: 7892 -
17c
Savarin C.Srogl J.Liebeskind LS. Org. Lett. 2002, 4: 4309 -
17d
Bakkestuen AK.Gundersen L.-L. Tetrahedron Lett. 2003, 44: 3359 -
17e
Strouse JJ.Jeselnik M.Tapaha F.Jonsson CB.Parker WB.Arterburn JB. Tetrahedron Lett. 2005, 46: 5699 -
17f
Benard S.Neuville L.Zhu J. J. Org. Chem. 2008, 73: 6441 -
17g
Guy CS.Jones TC. Synlett 2009, 2253 - 19
Ple PA.Green TP.Hennequin LF.Curwen J.Fennel M.Allen J.van der Brempt CL.Costello G. J. Med. Chem. 2004, 47: 871
References and Notes
General Procedure
for N-Arylation of 4 (3
H
)-Quinazolinone
A mixture of the
requisite 4 (3H)-quinazolinone (1.0 mmol), phenylboronic
acid (1.5 mmol), anhyd Cu(OAc)2 (1.0 mmol) and Et3N
(2.0 mmol) in dry CH2Cl2 (10-15 mL)
was stirred at ambient temperature under air for 24-70
h. Progress of the reaction was monitored by TLC. The reaction mixture
was filtered through Celite, the filtrate concentrated in vacuo,
and the resulting mixture purified by chromatography on silica gel
(CH2Cl2-MeOH) to yield the corresponding
N-substituted quinazolin-4 (3H)-one.
Selected Spectroscopic DataTable 1,
Entry 6
Brown solid; mp 221-223 ˚C.
IR (KBr): 3105, 3043, 2976, 2495, 1928 1614 cm-1. ¹H
NMR (400 MHz, DMSO-d
6): δ = 8.37
(s, 1 H), 8.14-8.12 (m, 1 H,), 7.95-7.93 (m, 1
H), 7.80-7.78 (m, 1 H), 7.62-7.60 (m, 2 H), 7.42-7.45
(m, 2 H). ¹³C NMR (50 MHz, CDCl3): δ = 159.0,
147.6, 146.4, 134.6, 131.6, 129.8, 129.6, 125.2, 116.2, 115.7. ESI-MS:
275 [M + H]+. ESI-HRMS: m/z calcd for C14H9ClFN2O [M + H]+: 275.0387;
found: 275.0383.
Table 1, Entry 7
Brown
solid; mp 194-196 ˚C. IR (KBr): 3066, 2981, 2939, 2727,
1681, 1556 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6): δ = 8.32
(s, 1 H), 8.17-8.15 (m, 1 H), 7.97-7.95 (m, 1
H) 7.76-7.73 (m, 1 H), 7.12-7.10 (m, 1 H), 7.03-6.98
(m, 2 H), 4.30 (s, 4 H). ¹³C NMR (50
MHz, CDCl3): δ = 159.0,
147.7, 146.3, 143.7, 143.2, 134.5, 131.4, 130.2, 129.4, 125.2, 123.1,
120.1, 117.0, 116.3, 64.0. ESI-MS: 315 [M + H]+. ESI-HRMS): m/z calcd for C16H12ClN2O3 [M + H]+: 315.0536;
found: 315.0529.
Table 1, Entry 8
Brown
solid; mp 190-192 ˚C. IR (KBr): 3086, 3026, 2962, 2654,
1739, 1610 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6): δ = 8.24
(s, 1 H), 7.58-7.48 (m, 6 H,), 7.20-7.18 (m, 1
H), 3.94 (s, 3 H), 3.89 (s, 3 H). ¹³C
NMR (50 MHz, CDCl3): δ = 159.2,
154.6, 148.9, 145.6, 143.8, 137.7, 129.1, 128.5, 127.4, 114.8, 108.0,
105.4, 56.0, 55.7. ESI-MS: m/z = 283 [M + H]+.
ESI-HRMS: m/z calcd for C16H15N2O3 [M + H]+: 283.1083;
found: 283.1081.
Table 1, Entry 9
Brown
solid; mp 243-245 ˚C. IR (KBr): 3433, 3060, 2962, 2837,
1683, 1610, 1502 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6): δ = 8.22
(s, 1 H), 7.49-7.47 (m, 1 H), 7.46-7.44 (m, 1 H),
7.39-7.37 (m, 2 H), 7.19-7.17 (m, 1 H), 3.94 (s,
3 H), 3.88 (s, 3 H), 2.30 (s, 3 H). ¹³C
NMR (50 MHz, CDCl3): δ = 161.4,
159.2, 154.68, 148.99, 145.64, 143.84, 133.65, 130.68, 126.9, 125.3,
115.6, 114.7, 108.0, 105.3, 56.02, 55.75, 14.07. ESI-MS: m/z 315 [M + H]+.
ESI-HRMS: m/z calcd for C17H16FN2O3 [M + H]+:
315.1145; found: 315.1143.
Selected Spectroscopic
DataTable 2, Entry 2
Brown solid; mp 125-127 ˚C.
IR (KBr): 3429, 3076, 2954, 2495, 2854 2445, 1678 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6): δ = 8.22
(s, 1 H), 7.60-7.58 (m, 2 H,),
7.56-7.54 (m, 1 H), 7.40-7.36 (m, 2 H), 7.20-7.18
(m, 1 H), 4.20-4.18 (m, 2 H), 3.85 (s, 3 H), 3.60-3.58
(m, 4 H), 2.46-2.38 (m, 6 H), 1.96-1.94 (m, 2
H). ¹³C NMR (50 MHz, CDCl3): δ = 164.0, 159.0,
153.9, 149.0, 145.5, 143.7,134.0, 133.8, 129.7, 129.5, 116.0, 115.6,
114.6, 108.6, 105.5, 66.9, 64.8, 55.7, 54.6, 53.0, 25.4. ESI-MS:
414 [M + H]+. ESI-HRMS: m/z calcd for C22H25FN3O4 [M + H]+:
414.1829; found: 414.1830.